IOLCP At
Meet us in Shanghai to discuss APIs and dependable pharma supply partnerships.
Contact Us
About CPHI & PMEC China 2026
CPHI & PMEC China brings global pharma professionals to Shanghai for sourcing, networking, learning, and face-to-face business across the pharmaceutical value chain.
For sourcing teams, quality leaders, technical teams, and partners, the event is more than an exhibition. It is where supplier conversations become clearer, product requirements become sharper, and future partnerships begin with a direct discussion.
About IOLCP
IOL Chemicals and Pharmaceuticals Limited is an India-based manufacturer of Active Pharmaceutical Ingredients, Intermediates, and Specialty chemicals with integrated operations and a global customer base.
Built on manufacturing depth, R&D capability, regulatory readiness, and long-term customer relationships, IOLCP supports pharma and chemical partners across multiple markets with a portfolio designed for dependable business conversations.
Learn moreWho we are
Founded 30 years ago, IOL Chemicals and Pharmaceuticals Limited is one of the most consistent pharma companies in delivering innovation-driven solutions to market needs.
35+
Years
120+
R&D experts
3000+
Workforce
Our Vison
To be amongst the most admired companies in APIs, Intermediaries, and Specialty Chemicals globally.
Know More
Our Mission
To provide top quality products in APIs, Intermediates and Specialty Chemicals through continuous innovation and cutting-edge technology, with due regards to safety and environment.
Know More
Our Values
We at IOL, believe values bring character to any organization that help leaders to guide teams for a culture of excellence through continuous improvements.
Know More
Our Portfolio
Our Milestones
-
1986
» 1986
IOL Chemicals and Pharmaceutical Limited was incorporated in 1986 with Acetic Acid Plant -
1996
» 1996
Commencement of Ethyl Acetate Plant -
1999
» 1999
Commencement of Acetic Anhydride Plant -
2000
» 2000
Commencement of Ibuprofen Unit-1 -
2007
» 2007
Established Unit-1 dedicated for Ibuprofen Established Multi fuel captive co-generation power plant of 4MW capacity -
2009
» 2009
Commencement of Iso Butyl Benezene, Mono Chloro Acetic Acid and Acetyl Chloride Plant leading to backward integration to Ibuprofen
-
2017
» 2017
Conversion of Unit-2 as dedicated facility for Ibuprofen -
2016
» 2016
Commencement of Unit-3 for new product launches -
2015
» 2015
USFDA EIR for Ibuprofen -
2013
» 2013
Received EUGMP certification -
2012
» 2012
Commencement of Unit-2 for Multi product -
2010
» 2010
IOL gets listed on the National Stock Exchange (NSE) Established Multi fuel captive co-generation power plant of 13MW capacity 2012
-
2018
» 2018
Established Unit-4 dedicated for Metformin Hydrochloride Unit-5 dedicated for Clopidogrel Bisulfate Form II & Fenofibrate -
2019
» 2019
Established Unit-6 dedicated for Pantoprazole Sodium -
2020
» 2020
Established Unit-7 dedicated for Metformin -
2021
» 2021
Established Unit-8 for Multi Products -
2022
» 2022
Began commercial production of Paracetamol -
2023
» 2023
Recommencement of Acetic Anhydride
Market Presence
